Elixiron Immunotherapeutics raised $27M Series A Plus venture round, led by Pangu Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Pangu CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
| Private Equity | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$40.8M
Top Valuation
-
Elixiron Immunotherapeutics raised $27M in a Series A Plus round.
The round was announced on 08/23/21.
The round was led by Pangu Capital.